Minimising delays to thrombolysis in patients developing acute myocardial infarction in hospital

A D Mumford1, A P Banning

  • 1Department of Cardiology, University, Hospital of Wales, Cardiff, UK.

Insights

Patients experiencing acute myocardial infarction (heart attack) symptoms often delay seeking help, leading to significant treatment delays. Early identification and direct admission to cardiac wards can improve outcomes for high-risk individuals.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Emergency Medicine

Background:

  • Acute myocardial infarction (AMI) requires prompt diagnosis and treatment.
  • In-hospital cardiac events can occur in patients admitted for other conditions.
  • Timeliness of treatment significantly impacts patient prognosis.

Purpose of the Study:

  • To compare clinical features and management of community- vs. in-hospital-acquired myocardial infarctions.
  • To identify factors contributing to delays in AMI treatment.
  • To evaluate the impact of initial ward admission on treatment and outcomes.

Main Methods:

  • Retrospective analysis of 100 patients (50 community-acquired AMI, 50 in-hospital cardiac events).
  • Review of clinical presentations, electrocardiograms (ECGs), and treatment records.
  • Comparison of time delays from symptom onset to thrombolysis.

Main Results:

  • A significant proportion of in-hospital events occurred within 24 hours of admission.
  • Chest pain and ECG evidence of ischemia identified high-risk patients.
  • Delays in seeking medical help were a major contributor to overall treatment delay.
  • In-hospital patients experienced shorter median delays to thrombolysis compared to community patients (120 vs. 287 minutes).

Conclusions:

  • Patients at high risk for AMI can be identified by chest pain and ECG findings.
  • Admission to non-specialist wards may lead to suboptimal treatment and delayed thrombolysis.
  • Direct admission of high-risk patients to a cardiac high-dependency unit for the initial 24 hours is recommended to improve care.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...